ArticleBone marrow transplantation2022

Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.

Stavroula Masouridi-Levrat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.